Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model

Adeno-associated virus (AAV) vectors expressing tumoricidal genes injected directly into brain tumors have shown some promise, however, invasive tumor cells are relatively unaffected. Systemic injection of AAV9 vectors provides widespread delivery to the brain and potentially the tumor/microenvironm...

Full description

Bibliographic Details
Main Authors: Crommentuijn, Matheus HW, Kantar, Rami, Noske, David P, Vandertop, W Peter, Badr, Christian E, Würdinger, Thomas, Maguire, Casey A, Tannous, Bakhos A
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916948/